查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971329

運動醫學市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、地區和競爭對手分類，2021-2031年

Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application (Knees, Shoulders, Ankle & Foot, Back & Spine, Elbow & Wrist, Hips, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球運動醫學市場預計將從 2025 年的 73.4 億美元成長到 2031 年的 104.2 億美元，複合年成長率為 6.01%。

此領域涵蓋專門的醫療設備、重組產品和輔助系統，旨在預防、診斷和治療運動傷害。推動這一領域成長的主要因素是全球日益成長的積極生活方式，這與需要臨床治療的肌肉骨骼創傷發生率的上升密切相關。例如，根據美國國家安全委員會的數據，預計到2024年，因運動和運動器材造成的損傷將達到564,845例，這意味著需要醫療干預的病例數量龐大，並推動了對整形外科解決方案和復健輔助器具的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 73.4億美元
市場規模：2031年 104.2億美元
複合年成長率：2026-2031年 6.01%
成長最快的細分市場 背部和脊柱
最大的市場 北美洲

然而，關節鏡手術和整形外科植入的高成本構成了市場准入的重大障礙。這些高昂的價格，加上各地不同的報銷政策，限制了病患獲得必要治療的機會，並阻礙了價格敏感市場對先進技術的應用。因此，這些經濟限制仍然是擴大市場滲透率和限制高品質醫療干預措施廣泛普及的重要障礙。

市場促進因素

微創外科技術的創新正在改變全球運動醫學市場，提高手術精確度並縮短患者復原時間。高清視覺化系統和機器人輔助技術在關節鏡手術中的應用，使外科醫生能夠以最小的組織損傷治療複雜的肌肉骨骼損傷，從而為這些專用器械的製造商帶來可觀的收入。史密斯醫療（Smith & Nephew）於2024年10月發布的2024年第三季財報清晰地印證了這一趨勢。報告指出，受視訊和切除平台強勁需求的推動，關節鏡手術輔助技術部門的收入成長了15.0%，凸顯了該產業對先進設備在改善臨床療效方面的高度依賴。

同時，全球體育健身活動的興起是市場成長的主要驅動力。這是因為隨著運動量的增加，運動傷害的發生率也在上升。這種上升趨勢在青少年和高中體育運動中尤其顯著，參與人數的增加擴大了需要預防和復健性整形外科護理的患者群體。根據美國高中體育協會聯合會（NFHS）於2024年8月發布的《2023-2024學年高中體育運動參與調查》，高中體育參與人數超過800萬，創歷史新高。如此活躍的人群支撐著主要企業的強勁業績；例如，史賽克公司報告稱，其醫療外科和神經技術部門在2024年第三季度的淨銷售額成長了12.8%。

市場挑戰

關節鏡手術和整形外科植入的高昂費用是全球運動醫學市場擴張的主要障礙。先進的重組產品和專用醫療設備往往價格昂貴，在發展中地區和預算緊張的醫療體系中難以取得。當醫療機構面臨資金限制時，它們被迫推遲引進這些關鍵技術或選擇更便宜的替代方案，造成經濟摩擦。這降低了製造商的銷售量，使其難以打入大眾市場，進而減緩了整體市場成長速度。

醫療報銷政策的不穩定性及其不斷下降加劇了這項挑戰，給醫療機構的營運預算帶來了沉重負擔。由於保險支付未能跟上通貨膨脹和營運成本上漲的步伐，醫療機構在資本投資方面變得更加謹慎。據美國整形外科學會稱，到2024年，聯邦醫療保險（Medicare）的醫生報銷比例將下降約3.37%，這將給骨科醫生帶來額外的經濟負擔。報銷能力的下降迫使醫療專業人員減少對高階運動醫學解決方案的投資，從而直接阻礙了新興工業技術的應用。

市場趨勢

隨著醫療服務提供者尋求更有效率、更經濟的運動醫學介入模式，整形外科手術向門診手術中心（ASC）的轉變正在從根本上改變市場結構。這項轉變的驅動力在於麻醉技術和微創技術的進步，這些進步使得即使是韌帶重組等複雜手術也能在門診安全進行。因此，製造商正專注於小型化設備和精簡的庫存管理系統，並調整產品線以滿足這些中心的特定需求。財務數據也印證了這項結構性變化。例如，泰尼特醫療（Tenet Healthcare）於2024年10月發布的2024年第三季財報顯示，其門診服務部門的淨營業收入年增21.0%，顯示該公司對這些機構的依賴程度日益加深。

同時，再生醫學和骨生物製藥的引入正在改變臨床策略，將重點從單純的機械固定轉向生物修復。臨床醫生正積極採用富血小板血漿（PRP）、骨移植替代物和透明質酸等治療方法來促進組織修復，並滿足患者對恢復自然生理功能的治療方法需求，從而延緩侵入性關節重建手術的必要性。這些生物解決方案的市場潛力在公司業績中得到了充分體現。在2024年11月發布的2024年第三季財報中，Bioventus公司報告稱，其全球收入同比成長15.0%，這主要得益於疼痛管理和外科解決方案的兩位數成長，凸顯了市場對主動修復技術的日益青睞。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球運動醫學市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（身體重組與修復（外科器械、軟組織修復、骨骼重組器械）、身體支撐與復健（矯正器具及其他支撐器材、壓力衣、冷熱療法）、身體監測與評估（心臟、呼吸、血液動力學、肌肉骨骼、其他）、配件（繃帶、膠帶、消毒劑、包紮帶、其他））
    • 按下應用部位（膝蓋、肩膀、腳踝/腳部、背部/脊椎、手肘/腕部、髖部、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美運動醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲運動醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區運動醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲運動醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美運動醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球運動醫學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Teva Pharmaceutical Industries Ltd.
  • Karl Storz SE & Co. KG
  • CONMED Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Breg Inc.
  • DJO Global, Inc.
  • Mueller Sports, Inc.
  • Wright Medical Group NV
  • Medtronic plc.
  • Performance Health International Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24007

The Global Sports Medicine Market is projected to expand from USD 7.34 Billion in 2025 to USD 10.42 Billion by 2031, registering a CAGR of 6.01%. This sector comprises specialized medical devices, body reconstruction products, and support systems aimed at preventing, diagnosing, and treating injuries resulting from physical activities. A key catalyst for this growth is the worldwide increase in active lifestyles, which correlates with a higher frequency of musculoskeletal trauma requiring clinical care. For example, data from the National Safety Council indicates that exercise and exercise equipment were responsible for an estimated 564,845 injuries in 2024, underscoring the significant volume of cases needing medical attention and fueling demand for orthopedic solutions and rehabilitation aids.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 7.34 Billion
Market Size 2031USD 10.42 Billion
CAGR 2026-20316.01%
Fastest Growing SegmentBack and Spine
Largest MarketNorth America

However, the market faces a substantial hurdle due to the high costs associated with arthroscopic procedures and orthopedic implants. These elevated prices, compounded by inconsistent reimbursement policies across various regions, restrict patient access to essential treatments and hinder the adoption of advanced technologies in price-sensitive markets. Consequently, these financial constraints remain a significant barrier preventing broader market penetration and limiting the widespread availability of premium medical interventions.

Market Driver

Technological innovations in minimally invasive surgical techniques are transforming the Global Sports Medicine Market by improving surgical accuracy and shortening patient recovery periods. The incorporation of high-definition visualization systems and robotic assistance into arthroscopic procedures enables surgeons to address complex musculoskeletal injuries with minimal tissue damage, driving significant revenue for manufacturers of these specialized tools. This trend is exemplified by Smith+Nephew's 'Third Quarter 2024 Trading Report' from October 2024, which noted a 15.0% revenue increase in their Arthroscopic Enabling Technologies segment, attributed to robust demand for their video and resection platforms, highlighting the industry's dependence on advanced equipment to enhance clinical outcomes.

Simultaneously, the rising global engagement in sports and physical fitness serves as a major driver for market growth, as increased activity levels lead to a higher incidence of sports-related injuries. This upward trend is especially notable in organized youth and high school athletics, where growing participation rates generate a larger patient pool needing preventive and restorative orthopedic care. According to the National Federation of State High School Associations' August 2024 '2023-24 High School Athletics Participation Survey', high school sports participation hit a record high of over 8 million. This active demographic supports strong financial results for major corporations; for instance, Stryker reported a 12.8% increase in net sales for its MedSurg and Neurotechnology segment in the third quarter of 2024.

Market Challenge

The substantial expense linked to arthroscopic procedures and orthopedic implants represents a major impediment to the expansion of the global sports medicine market. Advanced reconstruction products and specialized medical devices frequently come with premium price tags, limiting their attainability in developing regions and healthcare systems with strict budget constraints. When medical facilities face financial limitations, they are often compelled to postpone acquiring these essential technologies or select less costly alternatives, creating economic friction that reduces sales volumes for manufacturers and decelerates the overall rate of market growth by making mass market penetration financially difficult.

This challenge is further exacerbated by inconsistent and decreasing reimbursement policies, which place significant strain on the operational budgets of medical practices. As insurance payments struggle to match inflation and rising operational costs, healthcare providers are becoming more cautious regarding capital expenditures. According to the American Academy of Orthopaedic Surgeons, the Medicare Physician Fee Schedule conversion factor was cut by approximately 3.37 percent in 2024, imposing extra financial stress on orthopedic surgeons. This decline in reimbursement power compels practitioners to curtail investment in high-end sports medicine solutions, posing a direct barrier to the widespread adoption of emerging industry technologies.

Market Trends

The migration of orthopedic procedures toward Ambulatory Surgery Centers is fundamentally reshaping the market as providers search for more efficient and cost-effective delivery models for sports medicine interventions. This transition is driven by improvements in anesthesia and minimally invasive technologies, allowing complex surgeries like ligament reconstructions to be safely conducted in outpatient environments. Consequently, manufacturers are adapting their product lines to meet the specific needs of these centers by focusing on compact equipment and streamlined inventory systems. Financial data confirms this structural shift; for example, Tenet Healthcare's 'Third Quarter 2024 Earnings Release' in October 2024 reported a 21.0% year-over-year increase in net operating revenues for their Ambulatory Care segment, underscoring the growing reliance on these facilities.

Concurrently, the incorporation of regenerative medicine and orthobiologics is transforming clinical strategies by emphasizing biological healing over purely mechanical fixation. Clinicians are increasingly adopting therapies such as platelet-rich plasma, bone graft substitutes, and hyaluronic acid to expedite tissue repair and postpone the necessity for invasive joint replacements, addressing the need for treatments that restore natural physiology. The market potential of these biological solutions is evident in corporate performance; Bioventus reported in its 'Third Quarter 2024 Financial Results' in November 2024 that worldwide revenue rose by 15.0% year-over-year, led by double-digit growth in pain treatments and surgical solutions, highlighting the increasing preference for active healing technologies.

Key Market Players

  • Teva Pharmaceutical Industries Ltd.
  • Karl Storz SE & Co. KG
  • CONMED Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Breg Inc.
  • DJO Global, Inc.
  • Mueller Sports, Inc.
  • Wright Medical Group N.V.
  • Medtronic plc.
  • Performance Health International Limited

Report Scope

In this report, the Global Sports Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sports Medicine Market, By Product

  • Body Reconstruction & Repair (Surgical Equipment, Soft Tissue Repair, Bone Reconstruction Devices)
  • Body Support & Recovery (Braces and Other Support Devices, Compression Clothing, Hot & Cold Therapy)
  • Body Monitoring & Evaluation (Cardiac, Respiratory, Hemodynamic, Musculoskeletal, Others)
  • Accessories (Bandages, Tapes, Disinfectants, Wraps, Other)

Sports Medicine Market, By Application

  • Knees
  • Shoulders
  • Ankle & Foot
  • Back & Spine
  • Elbow & Wrist
  • Hips
  • Others

Sports Medicine Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sports Medicine Market.

Available Customizations:

Global Sports Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sports Medicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Body Reconstruction & Repair (Surgical Equipment, Soft Tissue Repair, Bone Reconstruction Devices), Body Support & Recovery(Braces and Other Support Devices, Compression Clothing, Hot & Cold Therapy), Body Monitoring & Evaluation(Cardiac, Respiratory, Hemodynamic, Musculoskeletal, Others), Accessories( Bandages, Tapes, Disinfectants, Wraps, Other))
    • 5.2.2. By Application (Knees, Shoulders, Ankle & Foot, Back & Spine, Elbow & Wrist, Hips, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Sports Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Sports Medicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Sports Medicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Sports Medicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Sports Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Sports Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Sports Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Sports Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Sports Medicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Sports Medicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Sports Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Sports Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Sports Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Sports Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Sports Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Sports Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Sports Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Sports Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Sports Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Sports Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Sports Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Sports Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Sports Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Sports Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Sports Medicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Teva Pharmaceutical Industries Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Karl Storz SE & Co. KG
  • 15.3. CONMED Corporation
  • 15.4. Smith & Nephew plc
  • 15.5. Stryker Corporation
  • 15.6. Breg Inc.
  • 15.7. DJO Global, Inc.
  • 15.8. Mueller Sports, Inc.
  • 15.9. Wright Medical Group N.V.
  • 15.10. Medtronic plc.
  • 15.11. Performance Health International Limited

16. Strategic Recommendations

17. About Us & Disclaimer